Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jul-Aug;19(4):621-5; discussion 625-6.
doi: 10.1007/BF00294738.

Optimal dose of garlic to inhibit dimethylhydrazine-induced colon cancer

Affiliations

Optimal dose of garlic to inhibit dimethylhydrazine-induced colon cancer

J Y Cheng et al. World J Surg. 1995 Jul-Aug.

Abstract

This study was designed to investigate the optimal dose of garlic during long-term feeding and its preventive and therapeutic effects on colon cancer in rats induced by 1,2-dimethylhydrazine (DMH). A total of 240 male Sprague-Dawley rats were grouped and fed with either a basal or a garlic diet of different concentration, and some groups were subcutaneously injected with DMH 20 mg/kg once a week for 20 weeks. The incidence of colon tumor was significantly decreased in the groups fed with 2.5%, 5%, and 10% garlic diets (p < 0.001). There was no distinct difference among these concentrations (p > 0.05). Therefore the minimal optimal dose of garlic to inhibit colon cancer was 2.5%. The equivalent dose of this concentration in humans is 4.76 g/m2 body surface/day. In a therapeutic study, the tumor-inducing interval in nude mice subcutaneously injected with colon cancer cells (CC-M2) was prolonged by a 2.5% garlic diet (p < 0.01). Thus smaller tumor volume and longer survival time were found in the garlic group than in the controls (p < 0.01). However, the growth rate of tumors was not markedly inhibited by garlic. All rats finally died within 18 weeks. This study suggested that a 2.5% garlic dose may be used mainly as an inhibitor to prevent colon cancers and improve survival time.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Surg Oncol. 1983 Sep;24(1):83-7 - PubMed
    1. J Natl Cancer Inst. 1972 Oct;49(4):969-88 - PubMed
    1. Mutat Res. 1985 Jul;143(3):127-9 - PubMed
    1. J Urol. 1986 Sep;136(3):701-5 - PubMed
    1. Carcinogenesis. 1987 Mar;8(3):487-9 - PubMed

Publication types